To assess the prognostic value of baseline HIV-1 DNA levels, a meta-analysis was conducted according to the PROSPERO protocol (CRD42024619050) based on data from studies published until March 4, 2025.
BackgroundImmune checkpoint inhibitor (ICI)-based combination therapy has opened a new avenue for the treatment of multiple malignancies including hepatocellular carcinoma (HCC). However, considering
Symptoms were remarkable similar across the 3 areas presented (spine, base of brain, brain). Spine and CN DLMs produce the same types of symptoms but localized to the area involved during early phases